Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 15 studies | 34% ± 20% | |
peripheral blood | 11 studies | 21% ± 5% | |
lung | 10 studies | 23% ± 8% | |
liver | 5 studies | 29% ± 12% | |
heart | 4 studies | 26% ± 5% | |
eye | 4 studies | 28% ± 16% | |
kidney | 4 studies | 20% ± 3% | |
adipose | 4 studies | 24% ± 5% | |
lymph node | 3 studies | 19% ± 3% | |
intestine | 3 studies | 23% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 3331.74 | 459 / 459 | 100% | 61.41 | 1118 / 1118 |
esophagus | 100% | 3674.47 | 1445 / 1445 | 100% | 42.97 | 183 / 183 |
liver | 100% | 2561.14 | 226 / 226 | 100% | 45.36 | 406 / 406 |
ovary | 100% | 2783.84 | 180 / 180 | 100% | 47.09 | 430 / 430 |
prostate | 100% | 3020.91 | 245 / 245 | 100% | 55.81 | 502 / 502 |
stomach | 100% | 2473.18 | 359 / 359 | 100% | 66.33 | 286 / 286 |
uterus | 100% | 2907.35 | 170 / 170 | 100% | 64.46 | 459 / 459 |
kidney | 100% | 3001.28 | 89 / 89 | 100% | 64.53 | 900 / 901 |
thymus | 100% | 3400.91 | 653 / 653 | 100% | 61.94 | 604 / 605 |
lung | 100% | 2999.72 | 577 / 578 | 100% | 53.99 | 1155 / 1155 |
intestine | 100% | 3019.49 | 966 / 966 | 100% | 79.12 | 526 / 527 |
bladder | 100% | 2591.71 | 21 / 21 | 100% | 73.96 | 503 / 504 |
brain | 100% | 1977.94 | 2635 / 2642 | 100% | 43.57 | 705 / 705 |
pancreas | 100% | 1652.91 | 327 / 328 | 100% | 58.56 | 178 / 178 |
skin | 100% | 4943.34 | 1809 / 1809 | 100% | 54.46 | 470 / 472 |
adrenal gland | 100% | 2708.82 | 258 / 258 | 96% | 25.25 | 221 / 230 |
adipose | 100% | 3109.57 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 54.40 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 45.45 | 29 / 29 |
muscle | 100% | 3336.85 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3293.66 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 49.89 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.39 | 1 / 1 |
blood vessel | 100% | 2687.89 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 2143.37 | 854 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 2157.16 | 915 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1904153 | Biological process | negative regulation of retrograde protein transport, ER to cytosol |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0070972 | Biological process | protein localization to endoplasmic reticulum |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | UBAC2 |
Protein name | Ubiquitin-associated domain-containing protein 2 (UBA domain-containing protein 2) (Phosphoglycerate dehydrogenase-like protein 1) UBA domain containing 2 |
Synonyms | PHGDHL1 PSEC0110 |
Description | FUNCTION: Restricts trafficking of FAF2 from the endoplasmic reticulum to lipid droplets . In association with LMBR1L and E3 ubiquitin-protein ligase AMFR, negatively regulates the canonical Wnt signaling pathway in the lymphocytes by promoting the ubiquitin-mediated degradation of CTNNB1 and Wnt receptors FZD6 and LRP6 . . |
Accessions | ENST00000474510.2 ENST00000403766.8 [Q8NBM4-1] Q5JUH4 A0A087WXT1 X6R5E5 ENST00000376440.6 [Q8NBM4-2] ENST00000355700.9 Q8NBM4 ENST00000457666.1 |